HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

propane-2-sulfonic acid octadec-9-enyl-amide

structure in first source

Also Known As:

N15 compound

Networked: 6 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Acids: 53217
  - Noncarboxylic Acids
    - Sulfur Acids
      - Sulfonic Acids: 1605
        propane-2-sulfonic acid octadec-9-enyl-amide: 6
- Sulfur Compounds: 278
  - Sulfur Acids
    - Sulfonic Acids: 1605
      - propane-2-sulfonic acid octadec-9-enyl-amide: 6
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfur Acids
    - Sulfonic Acids: 1605
      - propane-2-sulfonic acid octadec-9-enyl-amide: 6

Experts

1.	Li, Ying: 5 articles (10/2020 - 11/2017)
2.	Zhou, Juan: 3 articles (10/2020 - 12/2019)
3.	Ren, Tong: 3 articles (12/2019 - 11/2017)
4.	Jin, Xin: 3 articles (05/2018 - 10/2016)
5.	Peng, Lu: 3 articles (05/2018 - 10/2016)
6.	Cong, Ying: 2 articles (10/2020 - 01/2020)
7.	Lu, Huahui: 2 articles (10/2020 - 01/2020)
8.	Wang, Ying: 2 articles (01/2020 - 12/2019)
9.	Zhu, Maoshu: 2 articles (01/2020 - 12/2019)
10.	Xu, Lanxi: 2 articles (12/2019 - 11/2017)

Related Diseases

1.	Ischemic Stroke 12/18/2019 - "Our previous studies showed that propane-2-sulfonic acid octadec-9-enyl-amide (N15), a novel peroxisome proliferator-activated receptors α and γ (PPARα/γ) dual agonist, protected against ischaemia-induced acute brain damage in mice and improved cognitive ability in the chronic phase of ischaemic stroke. " 01/01/2020 - "Our previous reports demonstrated that the novel peroxisome proliferator-activated receptors α and γ (PPARα/γ) dual agonist propane-2-sulfonic acid octadec-9-enyl-amide (N15) alleviates cognitive ability in the chronic phase of ischemic stroke. "
2.	Insulin Resistance 05/05/2018 - "A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro."
3.	Myeloid Leukemia (Leukemia, Myelocytic) 10/14/2020 - "Our previous study showed that propane-2-sulfonic acid octadec-9-enyl-amide (N15), a novel peroxisome proliferator-activated receptor α and γ (PPARα/γ) dual agonist, inhibits inflammatory responses in tumor necrosis factor alpha (TNFα)-induced vascular endothelial cells or lipopolysaccharide (LPS)-induced human myeloid leukemia mononuclear cells-1. "
4.	Memory Disorders (Memory Loss) 01/01/2020 - "Propane-2-sulfonic acid octadec-9-enyl-amide alleviates scopolamine-induced spatial learning and memory deficits in mice."
5.	Ischemia 11/01/2017 - "Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses."

Related Drugs and Biologics

1.	Peroxisome Proliferator-Activated Receptors (PPAR)
2.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
3.	Lipopolysaccharides
4.	Scopolamine (Hyoscine)